What is the Hlb Panagene Co., Ltd. stock price forecast?

Hlb Panagene Co., Ltd. is currently trading at ₩1,590. View real-time AI analysis on Alpha Lenz.

What is Hlb Panagene Co., Ltd. insider trading activity?

View the latest insider trading data for Hlb Panagene Co., Ltd. on Alpha Lenz.

What is Hlb Panagene Co., Ltd.'s P/E ratio?

Hlb Panagene Co., Ltd.'s P/E ratio is -23.2.

Hlb Panagene Co., Ltd.

KRX · 046210

₩1,590+108(+7.29%)Market closed

Ask about Hlb Panagene Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Hlb Panagene Co., Ltd. trades at a P/E of -23.2 (undervalued) with modest ROE of -4.2%.”

Ask for details →

Company Overview

Hlb Panagene Co., Ltd. is a biotechnology company known for its expertise in developing molecular diagnostic products. It primarily focuses on the design and manufacture of peptide nucleic acid (PNA) probes, which are essential tools in genetic testing and research. These probes are utilized to enhance the precision and efficacy of detecting specific sequences of DNA or RNA, benefiting a variety of industries, including healthcare, biotechnology, and pharmacogenomics. With its innovative technology, Hlb Panagene plays a crucial role in the advancement of personalized medicine by enabling more accurate diagnoses and tailored treatment strategies. The company's commitment to research and development underscores its significance in fostering medical and scientific breakthroughs, contributing to a more effective healthcare environment globally.

CEO장인근

Websitehttps://www.panagene.com

SectorCommon Stock

IndustryCommon Stock

Company Statistics

FY 2025

Profile

₩72,389,456,400Market Cap

₩15,049,529,730Revenue

45.53MShares Out

0Employees

Margins

59.62%Gross

3.42%EBITDA

-22.86%Operating

-20.77%Pre-Tax

-20.77%Net

Valuation

-23.16P/E

1.00P/B

4.81EV/Sales

113.29EV/EBITDA

-28.48P/FCF

Growth (CAGR)

2.02%Rev 3Yr

-1.54%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-3.09%ROA

-4.21%ROE

-1.92%ROIC

Financial Health

₩29,746,807,990Cash & Cash Equivalents

₩-9,245,806,020Net Debt

28.30%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Hlb Panagene Co., Ltd. trades at a P/E of -23.2 (undervalued) with modest ROE of -4.2%.”

Ask for details →

Frequently Asked Questions

Hlb Panagene Co., Ltd. (ticker: 046210) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $72.4B.

The current price is ₩1,590 with a P/E ratio of -23.16x and P/B of 1x.

ROE is -4.21% and operating margin is -22.86%. Annual revenue is $15.0B.